Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.13935Source: DataRank Database

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy is a research paper published in JAMA Network Open (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 1.06)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Jillian R. Gunther ORCID,Penny Fang ORCID,Mikaela Bankston ORCID,Sarah A. Milgrom ORCID,David Boyce-Fappiano ORCID

Live enrichment

PubMed:32990738 PMC:PMC7525355 OpenAlex:https://openalex.org/W3090416958

FWCI

1.06

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770978/pinnix_2020_oi_200527_1600357368.24575.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770978/pinnix_2020_oi_200527_1600357368.24575.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2020.13935

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32990738

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7525355

Fields of Study

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentEsophageal Cancer Research and TreatmentAdultAntineoplastic Combined Chemotherapy ProtocolsBleomycinCombined Modality TherapyDacarbazineDisease-Free SurvivalDose-Response Relationship, RadiationDoxorubicinFemaleHodgkin DiseaseHumansKaplan-Meier EstimateLong Term Adverse EffectsMaleNeoplasm StagingOrgans at RiskPositron Emission Tomography Computed TomographyRadiation DosageRadiotherapyVinblastineABVD protocol

MeSH Terms

Long Term Adverse EffectsPositron Emission Tomography Computed TomographyAdultAntineoplastic Combined Chemotherapy ProtocolsBleomycinCombined Modality TherapyDacarbazineDose-Response Relationship, RadiationDoxorubicinFemaleHodgkin DiseaseHumansMaleNeoplasm StagingRadiation DosageRadiotherapyVinblastineDisease-Free SurvivalKaplan-Meier EstimateOrgans at Risk

Keywords

ABVDMedicineDacarbazineVinblastineRadiation therapyPositron emission tomographyStage (stratigraphy)BleomycinCommon Terminology Criteria for Adverse EventsNuclear medicineOncologyInternal medicineVincristineChemotherapy

Sustainable Development Goals

SDG 0: Good health and well-being